Clopidogrel and proton pump inhibitors are two medications that are commonly coprescribed to patients with acute coronary syndrome.

Findings do not support an increased risk of cardiovascular events among patients receiving both medications compared with patients only receiving clopidogrel.

Patients aged > 80 years receiving both medications may be at a higher risk than those only receiving clopidogrel; this finding warrants further research.